Financial report interval: 2025.07.01 - 2025.12.31
Preview: CHINARES PHARMA(03320) predict that the Revenue is 156.38 B (+13.11%), Beat estimate;the EBIT is 6.229 B (+27.25%), Beat estimate;the EPS is 0.352 (+173.9%), Beat estimate.